Bernard Denoyer
CIK: 0001397636
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OKYO
OKYO Pharma Ltd
Director
Discretionary Trading P&L
Holdings
About Denoyer Bernard
Denoyer Bernard (SEC CIK 0001397636) files insider reports with the SEC as Director of OKYO Pharma Ltd (OKYO).
Signal8 holds 2 ownership filings by Denoyer Bernard (1 Form 3, 1 Form 4), filed between Jun 2, 2026 and Jun 10, 2026. Those filings report 1 transaction, the latest on Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Denoyer Bernard's filings is in LONDON.
Recent filings by Denoyer Bernard
- Jun 8, 2026: Grant or award of OKYO derivative securities (Form 4, code A).
Other insiders filing for OKYO Pharma Ltd (OKYO)
- BRANCACCIO JOHN P, Director
- Dempsey Robert John, CHIEF EXECUTIVE OFFICER
- JACOB GARY S, CHIEF DEVELOPMENT OFFICER
- CERRONE GABRIELE M, Director
- Mantelli Flavio, CHIEF MEDICAL OFFICER
- Patil Rajkumar V., Chief Scientific Officer